1sc8: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:1sc8.png|left|200px]] | [[Image:1sc8.png|left|200px]] | ||
{{STRUCTURE_1sc8| PDB=1sc8 | SCENE= }} | {{STRUCTURE_1sc8| PDB=1sc8 | SCENE= }} | ||
===Urokinase Plasminogen Activator B-Chain-J435 Complex=== | ===Urokinase Plasminogen Activator B-Chain-J435 Complex=== | ||
{{ABSTRACT_PUBMED_15150279}} | {{ABSTRACT_PUBMED_15150279}} | ||
==About this Structure== | ==About this Structure== | ||
[[1sc8]] is a 1 chain structure of [[Urokinase]] with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1SC8 OCA]. | |||
==See Also== | |||
*[[Urokinase|Urokinase]] | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:015150279</ref><references group="xtra"/> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: U-plasminogen activator]] | [[Category: U-plasminogen activator]] | ||
| Line 39: | Line 30: | ||
[[Category: Zeslawska, E.]] | [[Category: Zeslawska, E.]] | ||
[[Category: Human]] | [[Category: Human]] | ||
[[Category: Hydrolase]] | |||
[[Category: Inhibitor]] | [[Category: Inhibitor]] | ||
[[Category: Serine protease]] | [[Category: Serine protease]] | ||
[[Category: Urokinase]] | [[Category: Urokinase]] | ||
Revision as of 18:51, 25 July 2012
Urokinase Plasminogen Activator B-Chain-J435 ComplexUrokinase Plasminogen Activator B-Chain-J435 Complex
Template:ABSTRACT PUBMED 15150279
About this StructureAbout this Structure
1sc8 is a 1 chain structure of Urokinase with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See AlsoSee Also
ReferenceReference
- ↑ Schweinitz A, Steinmetzer T, Banke IJ, Arlt MJ, Sturzebecher A, Schuster O, Geissler A, Giersiefen H, Zeslawska E, Jacob U, Kruger A, Sturzebecher J. Design of novel and selective inhibitors of urokinase-type plasminogen activator with improved pharmacokinetic properties for use as antimetastatic agents. J Biol Chem. 2004 Aug 6;279(32):33613-22. Epub 2004 May 18. PMID:15150279 doi:10.1074/jbc.M314151200